Glycolysis fuels phosphoinositide 3-kinase signaling to bolster T cell immunity K Xu, N Yin, M Peng, EG Stamatiades, A Shyu, P Li, X Zhang, MH Do, ... Science 371 (6527), 405-410, 2021 | 272 | 2021 |
Cancer immunotherapy via targeted TGF-β signalling blockade in TH cells S Li, M Liu, MH Do, C Chou, EG Stamatiades, BG Nixon, W Shi, X Zhang, ... Nature 587 (7832), 121-125, 2020 | 193 | 2020 |
Bhlhe40 controls cytokine production by T cells and is essential for pathogenicity in autoimmune neuroinflammation CC Lin, TR Bradstreet, EA Schwarzkopf, J Sim, JA Carrero, C Chou, ... Nature communications 5 (1), 3551, 2014 | 193 | 2014 |
TGF-β suppresses type 2 immunity to cancer M Liu, F Kuo, KJ Capistrano, D Kang, BG Nixon, W Shi, C Chou, MH Do, ... Nature 587 (7832), 115-120, 2020 | 172 | 2020 |
c-Myc-induced transcription factor AP4 is required for host protection mediated by CD8+ T cells C Chou, AK Pinto, JD Curtis, SP Persaud, M Cella, CC Lin, BT Edelson, ... Nature immunology 15 (9), 884-893, 2014 | 118 | 2014 |
The transcription factor AP4 mediates resolution of chronic viral infection through amplification of germinal center B cell responses C Chou, DJ Verbaro, E Tonc, M Holmgren, M Cella, M Colonna, ... Immunity 45 (3), 570-582, 2016 | 102 | 2016 |
IL-1–induced Bhlhe40 identifies pathogenic T helper cells in a model of autoimmune neuroinflammation CC Lin, TR Bradstreet, EA Schwarzkopf, NN Jarjour, C Chou, ... Journal of Experimental Medicine 213 (2), 251-271, 2016 | 95 | 2016 |
Glycolytic ATP fuels phosphoinositide 3-kinase signaling to support effector T helper 17 cell responses K Xu, N Yin, M Peng, EG Stamatiades, S Chhangawala, A Shyu, P Li, ... Immunity 54 (5), 976-987. e7, 2021 | 84 | 2021 |
Cytotoxic granzyme C–expressing ILC1s contribute to antitumor immunity and neonatal autoimmunity BG Nixon, C Chou, C Krishna, S Dadi, AO Michel, AE Cornish, ... Science immunology 7 (70), eabi8642, 2022 | 67 | 2022 |
Reprogramming tumour-associated macrophages to outcompete cancer cells X Zhang, S Li, I Malik, MH Do, L Ji, C Chou, W Shi, KJ Capistrano, ... Nature 619 (7970), 616-623, 2023 | 64 | 2023 |
Programme of self-reactive innate-like T cell-mediated cancer immunity C Chou, X Zhang, C Krishna, BG Nixon, S Dadi, KJ Capistrano, ... Nature 605 (7908), 139-145, 2022 | 64 | 2022 |
Tissue-resident lymphocytes across innate and adaptive lineages C Chou, MO Li Frontiers in immunology 9, 2104, 2018 | 56 | 2018 |
Runx1 and Cbfβ regulate the development of Flt3+ dendritic cell progenitors and restrict myeloproliferative disorder AT Satpathy, CG Briseño, X Cai, DG Michael, C Chou, S Hsiung, ... Blood, The Journal of the American Society of Hematology 123 (19), 2968-2977, 2014 | 56 | 2014 |
BCL6-dependent TCF-1+ progenitor cells maintain effector and helper CD4+ T cell responses to persistent antigen Y Xia, K Sandor, JA Pai, B Daniel, S Raju, R Wu, S Hsiung, Y Qi, ... Immunity 55 (7), 1200-1215. e6, 2022 | 55 | 2022 |
Pathogenic mechanisms of hypertrophic cardiomyopathy beyond sarcomere dysfunction C Chou, MT Chin International journal of molecular sciences 22 (16), 8933, 2021 | 44 | 2021 |
Nutrient mTORC1 signaling underpins regulatory T cell control of immune tolerance MH Do, X Wang, X Zhang, C Chou, BG Nixon, KJ Capistrano, M Peng, ... Journal of Experimental Medicine 217 (1), e20190848, 2019 | 38 | 2019 |
A silencer-proximal intronic region is required for sustained CD4 expression in postselection thymocytes DM Henson, C Chou, N Sakurai, T Egawa The Journal of Immunology 192 (10), 4620-4627, 2014 | 32 | 2014 |
Reprogramming tumor-associated macrophages to outcompete endovascular endothelial progenitor cells and suppress tumor neoangiogenesis MH Do, W Shi, L Ji, E Ladewig, X Zhang, RM Srivastava, KJ Capistrano, ... Immunity 56 (11), 2555-2569. e5, 2023 | 18 | 2023 |
Re (de) fining innate lymphocyte lineages in the face of cancer C Chou, MO Li Cancer immunology research 6 (4), 372-377, 2018 | 10 | 2018 |
Myc or no Myc, that is the question C Chou, T Egawa The EMBO Journal 34 (15), 1990-1991, 2015 | 9 | 2015 |